35 related articles for article (PubMed ID: 26696338)
1. Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
Yeruva SLH; Javadi MS; Stearns V
Clin Breast Cancer; 2018 Jun; 18(3):e277-e280. PubMed ID: 29398467
[No Abstract] [Full Text] [Related]
2. Reassessing treatment strategies for DCIS: analysis of survival and recurrence patterns.
Mokbel K; Alamoodi M
Breast Cancer Res Treat; 2024 Jun; 205(2):423-424. PubMed ID: 38361145
[No Abstract] [Full Text] [Related]
3. A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.
Klimov S; Miligy IM; Gertych A; Jiang Y; Toss MS; Rida P; Ellis IO; Green A; Krishnamurti U; Rakha EA; Aneja R
Breast Cancer Res; 2019 Jul; 21(1):83. PubMed ID: 31358020
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ.
Bosch DE; Kilgore MR; Schmidt RA; Swanson PE; Rendi MH; Chang OH
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):543-547. PubMed ID: 28885232
[TBL] [Abstract][Full Text] [Related]
5. Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?
Poulakaki N; Makris GM; Battista MJ; Böhm D; Petraki K; Bafaloukos D; Sergentanis TN; Siristatidis C; Chrelias C; Papantoniou N
Breast; 2016 Feb; 25():57-61. PubMed ID: 26612082
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
7. Some clarity in the management of DCIS in breast cancer screening.
Wald NJ
J Med Screen; 2011; 18(3):112. PubMed ID: 22045817
[No Abstract] [Full Text] [Related]
8. Using IHC to Predict Local Recurrence/Progression of DCIS: A Search for a More Cost-effective Solution.
Kilgore MR; Chang OH; Swanson PE; Schmidt RA; Garcia RL; Rendi MH
Breast J; 2016; 22(2):247-8. PubMed ID: 26696338
[No Abstract] [Full Text] [Related]
9. Actual management of ductal carcinoma in situ of the breast.
Maass N; Alkasi O; Bauer M; Jonat W; Souchon R; Meinhold-Heerlein I
Arch Gynecol Obstet; 2009 Nov; 280(5):699-705. PubMed ID: 19259692
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
Mardekian SK; Bombonati A; Palazzo JP
Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
